Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]

Cardiology General

SGLT2 Inhibitors & Cardiac Results in Anthracycline Patients

Sep 13, 2022

Patients with chronic heart failure fare better when treated with sodium-glucose co-transporter-2 (SGLT2) inhibitors. There was no information on the benefit of SGLT2 inhibitors among patients treated...

Expenditure on Heart Failure (HF) in the United States

Sep 13, 2022

Estimating current spending for patients with heart failure (HF) informs the worth of preventative health initiatives, which is important given the rising cost of healthcare in the United States. This...

Supranormal LVEF, Stroke Volume, and Cardiovascular Risk

Sep 13, 2022

An elevated cardiovascular disease (CVD) risk has been linked to echocardiographic evidence of a supranormal ejection fraction in patient populations referred for clinical care. Supranormal left ventr...

Predictors of Major Adverse Cardiovascular Outcomes in CHD

Aug 31, 2022

Clinicians need to implement strategies that improve adherence to and greater use of intensive therapies in secondary cardiovascular disease prevention. Patients with established coronary heart...

Antihypertensive & Statin Adherence Suboptimal in Medicare Recipients

Aug 29, 2022

In Medicare beneficiaries, antihypertensive and statin medication adherence was found to be suboptimal, and disparities were present. Hypertension and hypercholesterolemia are leading chronic ...

Left-Sided VHD Detection: Deep Learning ECG Analysis

Aug 23, 2022

Valvular heart disease continues to go undiagnosed while being a significant cause of cardiovascular morbidity and death. Electrocardiography (ECG) deep learning analysis may help identify mitral regu...

Cardiorespiratory Fitness & Mortality Risk Across Age, Race, and Sex

Aug 23, 2022

All-cause mortality and cardiorespiratory fitness (CRF) are negatively correlated. The relationship between CRF and mortality risk for various racial groups, women, and old people has not yet been tho...

SR Ivabradine Hemisulfate in Systolic Heart Failure Patients

Aug 23, 2022

Ivabradine works well to lower heart rate and enhance therapeutic outcomes in chronic heart failure patients with low ejection fraction (HFrEF). However, only the short-acting ivabradine formulation, ...

Cardiovascular (CV) Disease Projections in the United States

Aug 23, 2022

Planning for public health interventions and understanding changes in cardiovascular (CV) risk factors and illness by age, sex, race, and ethnicity are crucial. For a study, researchers sought to esti...

PVD Spectrum: Clinical Features and Transplant-Free Survival

Aug 23, 2022

Deep phenotyping will be used by PVDOMICS (Pulmonary Vascular Disease Phenomics), a precision medicine program, to describe pulmonary vascular disease (PVD). PVDOMICS investigates the claim that combi...

Balloon- vs Self-Expanding Valve Systems: Failed Small Surgical Aortic Valve Bioprostheses

Aug 23, 2022

Retrospective studies have provided information on valve system comparisons in the field of valve-in-valve transcatheter aortic valve replacement (ViV-TAVR). For a study, researchers sought to compare...

Discordant Grading & Flow-Gradient Patterns in Moderate AS

Aug 23, 2022

Discordant grading in severe aortic stenosis (AS) has well-known prognostic repercussions. The incidence of various flow-gradient patterns and the consequences for prognosis in mild AS remained unclea...

PCSK9 and HMG-CoA Reductase Inhibition & Cognitive Function

Aug 23, 2022

Although proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and statin-based lipid-lowering medication are effective methods for lowering the risk of cardiovascular disease, worries rega...

Socioeconomic Status With Hypertension in LMICs

Aug 22, 2022

Understanding the existing socioeconomic gradients of hypertension and how they are anticipated to alter as nations improve economically is necessary for effective equity-focused health policies for t...

Impact of Cardiac Damage After AVR: Prognosis and Evolution

Aug 22, 2022

It was uncertain how aortic valve replacement (AVR) affects the progression/regression of extra valvular cardiac injury and its relationship to eventual prognosis. For a study, researchers sought to e...

Medication Nonadherence in Dual Antiplatelet Therapy

Aug 22, 2022

After percutaneous coronary intervention (PCI), antiplatelet treatment nonadherence is typical, even in clinical studies. For a study, researchers sought to determine how non-compliance with the study...

Medication Adherence With Health Outcomes: ISCHEMIA Trial

Aug 22, 2022

Participants with chronic coronary disease (CCD) were randomized in the ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) to medical care followin...

TAVI In-Hospital Outcomes & Readmission Rates in MAVD vs. AS

Aug 17, 2022

For a study, researchers sought to see how patients with mixed aortic valve disease (MAVD) fared regarding in-hospital outcomes and readmission rates. Using procedure codes from the Nationwide Readmis...

Cardiac CARE Trial: Anthracycline Cardiotoxicity Prevention

Aug 10, 2022

The severity of anthracycline-induced cardiotoxicity was widely varied, and no treatment option has been shown to be effective. In unselected patients, β-adrenergic receptor blockers and renin-angiot...

Donor Utilization: Effect of Sex, Drugs, & Increased Risk

Aug 10, 2022

Even though there has been an increase in the number of heart transplants performed recently, only around one-third of potential donors were usually accepted for the procedure. It was unknown whether ...